Mass.-based biotech company Editas Medicine Inc. appointed Jessica Hopfield as a board member.
Hopfield is the chairperson of the board for Joslin Diabetes Center and serves as the lead independent director on the board at Insulet Corp.
Editas Medicine names board member
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Mass.-based biotech company Editas Medicine Inc. appointed Jessica Hopfield as a board member.
Hopfield is the chairperson of the board for Joslin Diabetes Center and serves as the lead independent director on the board at Insulet Corp.